Avicenna.AI radiology AI products

Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Which exact product, version and licensed modules are in the current offer?
Do related FDA submissions document the same scope, or different functions and versions?
Which costs, support obligations and local acceptance tests remain unresolved?

Prepare with a buyer guide:

Radiology AI pricing and total cost of ownership

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K240942

CINA-CSpine

Avicenna.AI

Authorized purpose: Assist hospital networks and appropriately trained physician specialists by flagging suspected acute cervical-spine fractures on cervical-spine CT for triage and prioritization; it is not designed to detect vertebral compression fractures.

Modality: CT/CTA
Anatomy: Cervical spine; acute cervical-spine fractures including non-displaced lines and displaced fragments
Decision: 2024-09-12

FDA-cleared K240612

CINA-VCF

Avicenna.AI

Authorized purpose: Parallel worklist triage for suspected vertebral compression fractures in patients aged 50 years and over within the standard-of-care bone-health setting; not a diagnostic device

Modality: CT/CTA
Anatomy: Thoracic and lumbar vertebrae T1-L5 within chest and/or abdomen CT
Decision: 2024-05-31

MSK and bone Acute triage and notification

FDA-cleared K233342

CINA-ASPECTS

Avicenna.AI

Authorized purpose: CADx assistance for assessment and characterization of brain tissue abnormalities and early ischemic injury in patients with known MCA or ICA occlusion, using ASPECTS regions and scoring to evaluate extent of disease during image interpretation.

Modality: CT/CTA
Anatomy: Brain, including ASPECTS regions
Decision: 2024-03-15

Detection and CADe

FDA-cleared K233968

CINA-iPE

Avicenna.AI

Authorized purpose: Worklist triage and notification for suspected incidental pulmonary embolism on contrast-enhanced CT acquired for another indication; not a diagnostic device

Modality: CT/CTA
Anatomy: Lung and pulmonary arterial segments containing incidental pulmonary embolism; subsegmental arteries are out of scope
Decision: 2024-03-13

Pulmonary embolism Quantification and segmentation Acute triage and notification

FDA-cleared K221716

CINA

AVICENNA.AI

Authorized purpose: CINA analyzes non-enhanced head CT and head CTA DICOM in parallel with standard interpretation to flag suspected intracranial hemorrhage and anterior-circulation large-vessel occlusion (distal ICA, MCA-M1 or proximal MCA-M2), issuing worklist and active notifications with informational previews for trained-radiologist triage; it does not diagnose or alter original images.

Modality: CT/CTA
Anatomy: Brain
Decision: 2022-11-22

Stroke and ICH triage Acute triage and notification

FDA-cleared K210237

CINA CHEST

Avicenna.AI

Authorized purpose: Radiological computer-aided triage and notification for chest CTA suspected pulmonary embolism and chest or thoraco-abdominal CTA suspected aortic dissection, assisting hospital networks and trained radiologists with workflow prioritization in parallel with standard-of-care interpretation.

Modality: CT/CTA
Anatomy: Chest and thoraco-abdominal aorta
Decision: 2021-05-19

Pulmonary embolism Detection and CADe Acute triage and notification

FDA-cleared K200855

CINA

AVICENNA.AI

Authorized purpose: CINA analyzes nonenhanced head CT for suspected intracranial hemorrhage and head CTA for suspected large-vessel occlusion for computer-aided triage and notification in parallel with standard care; the output is not a primary diagnosis.

Modality: CT/CTA
Anatomy: Brain
Decision: 2020-06-24

Stroke and ICH triage Detection and CADe Acute triage and notification